TENKU — Citius Oncology Cashflow Statement
0.000.00%
Last trade - 00:00FinancialsSmall Cap
- $292.74m
- $294.22m
Annual cashflow statement for Citius Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -0.01 | 0.381 | 2.42 |
| Non-Cash Items | — | -0.493 | -3.43 |
| Other Non-Cash Items | |||
| Changes in Working Capital | 0.01 | 0.064 | 0.412 |
| Change in Prepaid Expenses | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | 0 | -0.048 | -0.601 |
| Other Investing Cash Flow Items | — | -67.3 | -1.32 |
| Purchase of Investments | |||
| Cash from Investing Activities | — | -67.3 | -1.32 |
| Financing Cash Flow Items | — | 1.76 | 0.345 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | — | 67.7 | 1.66 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0 | 0.289 | -0.256 |